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2 
Abstract 
 
PET/CT is starting to play an important role in evaluating fever of unknown origin (FUO), due to 
its ability to localize and delineate areas of high metabolic activity, such as neoplastic proliferation 
and inflammation, including vasculitis. We present a case of giant cell arteritis (GCA) in a 72 year 
old female patient admitted to our department with a four month history of FUO, weight loss and 
fatigue, without specific symptoms or signs. Laboratory investigations suggested acute phase 
response, with a pronounced erythrocyte sedimentation rate (ESR), high CRP level and microcytic 
anemia. A thorough diagnostic evaluation was performed in order to exclude an unknown primary 
tumor which was initially suspected due to a positive family history of cancer. Surprisingly, 
PET/CT revealed large vessel vasculitis affecting the ascending, descending and abdominal aorta, 
as well as subclavian, proximal brachial and carotid arteries bilaterally. Biopsy of the superficial 
temporal artery confirmed the diagnosis of GCA. Treatment with methylprednisolone and 
azathioprine led to resolution of clinical symptoms and normalization of laboratory parameters. In 
addition to the use of PET/CT in the evaluation of FUO, its value as a method complementary to 
temporal artery biopsy is also discussed. 
 
Keywords: fever of unknown origin (FUO), PET/CT, giant cell arteritis (GCA), 
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Abbreviations:  
FUO: fever of unknown origin;  
ESR: erythrocyte sedimentation rate;  
CRP: C reactive protein;  
GCA: giant cell arteritis;  
PMR: polymyalgia rheumatica;  
PET: positron emission tomography;  
FDG: 2-deoxy-2-[18F]fluoro-D-glucose;  
CT: computed tomography;  
MSCT: multislice CT;  
SUVmax: maximum standard uptake value;  
SUVs: standard uptake values 
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Introduction 
Fever of unknown origin (FUO) is classically defined as fever of at least 38.3ºC on several 
occasions, lasting for more than three weeks. In addition, an uncertain diagnosis after three days 
despite adequate in-hospital investigations or three out-patient visits is also an integral part of the 
definition [1]. 
A variety of possible clinical entities should be considered in the workup of FUO: infectious 
diseases, chronic granulomatous non-infectious diseases, oncological and hematological diseases, 
as well as inflammatory rheumatic conditions, including connective tissue diseases and 
vasculitides [2, 3, 4].  
Vasculitides are a heterogenous group of diseases characterized by vessel wall inflammation, 
leukocyte infiltration and reactive damage to mural structures and surrounding tissues [5].  Patients 
with different types of vasculitis may present with constitutional symptoms, such as fever and 
weight loss. This may be accompanied by an elevated erythrocyte sedimentation rate (ESR) and C 
reactive protein (CRP) level, along with abnormalities of other laboratory results, suggesting acute 
phase response [6].  
Giant cell arteritis (GCA) is the most common form of systemic vasculitis in adults, especially 
among the elderly female population. The highest incidence is found in northern Europe and 
Minnesota (USA); rates are lower in Mediterranean countries. GCA is a granulomatous 
inflammation involving large- and medium-sized arteries. In addition to previously mentioned 
nonspecific symptoms, it may present with headache, jaw claudication, toothache and sudden 
visual loss (usually unilateral), as well as limb claudication in rare cases. Moreover, approximately 
one half of patients with GCA have polymyalgia rheumatica (PMR), a condition characterized by 
shoulder and pelvic girdle morning stiffness and pain. Nevertheless, symptoms of GCA may be 
absent or constitutional, as already mentioned [7]. 
Positron emission tomography (PET) scans with 2-deoxy-2-[18F]fluoro-D-glucose (FDG) 
combined with computed tomography (CT) is starting to play an important role in evaluating 
FUO. FDG is a radioactive and nonmetabolizable analog of glucose accumulating in metabolically 
active cells. High uptake of FDG is normally observed in the brain, myocardium, kidneys and the 
urinary bladder.  However, the diagnostic use of PET is based on the high uptake of FDG into 
malignant and inflammatory cells. PET/CT is superior to PET alone, due to its greater ability to 
delineate areas of high FDG uptake [8, 9].  
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We present an unusual case of a patient presenting with FUO, suspected as large vessel vasculitis 
by PET/CT and confirmed as GCA by biopsy of the superficial temporal artery.  
Report of Case 
A 72 year old Caucasian female was referred to our department with a four month history of 
excessive fatigue, fever up to 38.5ºC with occasional rigors and a 6 kilogram body weight loss due 
to lack of appetite. There was no leading sign or symptom suggesting infectious disease. Urine 
cultures were positive for E. coli and the patient was treated accordingly. The control urine culture 
was negative. Nevertheless, the previously mentioned symptoms persisted.  
The patient denied night sweats, muscle weakness and dryness of the eyes and mouth. She also 
denied jaw claudication, headache, toothache and sudden visual impairment. Moreover, there was 
no history of upper or lower limb claudication, abdominal or chest pain. 
Prior to onset of the symptoms, the patient's history was unremarkable, apart from essential arterial 
hypertension, which was diagnosed 17 years ago and has been treated since then. She also 
underwent a diagnostic evaluation 20 years ago because of a positive PPD test. However, 
tuberculosis was not confirmed. The patient's father suffered from cancer of the upper jaw, 
although the exact type of the cancer was unknown to our patient.  
She was admitted to our department for further evaluation. She was subfebrile 37.5ºC on physical 
examination. A systolic murmur was audible over the entire precordium, with a punctum maximum 
in the projection of the apex. Blood pressure was elevated (160/90 mmHg) and equal on both 
arms. Skin examination did not reveal any rashes. There was no scalp tenderness or decrease of 
temporal artery pulsations. Other findings on physical examination were unremarkable. There 
were no physical signs of vascular insufficiency or malignancy, except for the weight loss. 
Musculoskeletal examination was completely normal, with a normal range of motion and no signs 
of synovitis.  
Laboratory investigations suggested acute phase response (Table 1).  
The PPD skin test was positive (15 mm in diameter), as well as the Quantiferone test for detecting 
M. tuberculosis.  
Results of ECG, chest X-ray, X-ray of the lumbosacral spine, pelvis and both hips, bone marrow 
cytology, abdominal and pelvic ultrasound and multislice CT (MSCT), colonoscopy, 
esophagogastroduodenoscopy, gynaecologic examination and transvaginal ultrasound came back 
5 
unremarkable, except for several diverticula of the large intestine, without signs of diverticulitis. 
Echocardiography revealed a hemodinamically insignificant pericardial effusion. Furthermore, 
technetium-99m bone scan revealed mild accumulation in the right hip and right knee, most likely 
of degenerative origin. 
The previously described detailed evaluation did not reveal the cause of the patient's clinical 
presentation. An unknown primary tumor was suspected considering the family history of cancer. 
Therefore, an integrated FDG-PET/CT was performed.  
Coronal and sagittal views on the integrated PET/CT revealed diffusely increased accumulation of 
FDG in the walls of large arteries, including the ascending, descending and abdominal aorta, as 
well as subclavian, proximal brachial and carotid arteries bilaterally, suggesting large vessel 
vasculitis. The maximum standard uptake value (SUVmax) was 3.7 (Figure 1). Diffusely 
inhomogenous accumulation was observed in the area of the spine, with a small focal 
accumulation in the region of the Th12 vertebra, as well as the S2 region, without a defined 
morphological substrate or evidence of secundarism (SUVmax 3.8). A mild diffuse accumulation 
was also noticed in the spleen (SUVmax 2.1).  
Although there were no symptoms of headache or visual impairment, GCA was strongly suspected 
given the patient's age and previously mentioned findings. Biopsy of the left superficial temporal 
artery was performed. It revealed an inflammatory granulomatous reaction that included 
histiocytes, giant multinuclear cells and lymphocytes. The inflammatory reaction fragmented the 
internal and external elastic lamina. This pattern was compatible with GCA (Figure 2).  
Based on the findings of the integrated PET/CT and temporal artery biopsy, the patient was 
diagnosed with GCA.  
Treatment was started with methylprednisolone 32 mg (0.5 mg/kg) daily for the first two weeks, 
along with daily azathioprine and aspirin (50 mg and 100 mg, respectively). Pantoprazole, 
alendronic acid, cholecalciferol and calcium supplementation were added to the treatment from the 
beginning, in order to prevent side effects. The treatment led to a prompt resolution of symptoms 
and a decrease of ESR and CRP, as well as normalization of red blood count levels. 
Methylprednisolone was tapered according to the clinical course. At a follow-up visit ten months 
after the beginning of treatment, the patient was in remission receiving 4 mg methylprednisolone 
daily, including other medications as mentioned previously. During the observed ten-month period 
the patient regained 5 kilograms and felt generally good.  
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Discussion 
Several diagnostic methods are recommended for the evaluation of FUO, including nuclear 
imaging [10]. Nuclear imaging detects functional and metabolic changes even before a 
morphological correlate develops.  PET is a nuclear imaging method based on the uptake of FDG 
by metabolically active cells. FDG has shown to be a useful tracer, since it accumulates in both 
malignant and inflammatory cells, covering more than 50% of possible causes of FUO, including 
vasculitis [8, 9]. FDG scans are more sensitive (77% to 92% in untreated patients) and specific 
(89-100% in untreated patients) in detecting vessel wall inflammation compared to gallium-67 
scans. Thus, a smaller number of cases remains undiagnosed. Additionally, data suggest that the 
level of FDG accumulation is associated with disease activity. This is potentially useful in the 
follow-up of patients with vasculitis [11, 12, 13]. PET combined with CT allows more precise 
anatomic localization and better spatial resolution in delineating areas of FDG uptake, being 
superior to PET alone [8, 9].  
On the other hand, it is important to notice that vasculitis is not the most common cause of 
increased FDG uptake in blood vessel walls. Atherosclerosis is the most common inflammatory 
condition of the arteries, hence it is more often responsible for an increased FDG uptake. This may 
lead to a false positive result in patients otherwise suspected with vasculitis. Thus, it is important 
to distinguish large vessel vasculitis from atherosclerosis on PET/CT. Mean standard uptake 
values (SUVs) of atherosclerotic arteries increase with age and are up to 2.01±0.50 in the eldest 
group of patients [14], similar to the values of vessels affected by vasculitis. Therefore, the 
distinction should be made not only on the basis of SUVs, but pathoanatomic properties and 
distribution of the affected vascular segments should also be taken into account [15]. If none of 
these criteria lead to a diagnostic conclusion, an ex iuvantibus steroid trial may be useful.  
Vasculitides are categorized into three groups, according to vessel size [16, 17]. Large vessel 
vasculitis represents about 17% of all FUO cases among patients over 50 years of age [3, 4]. GCA 
is the most common cause of large vessel vasculitis, predominantly involving the proximal aorta 
and its branches, and characterized by a granulomatous inflammation of the vessel wall [5]. It may 
present with vascular insufficiency and/or constitutional symptoms. Methods used in the 
evaluation of GCA are temporal artery biopsy, color duplex ultrasonography,  angiography, MRI, 
scintigraphy, FDG-PET, and integrated FDG-PET/CT [8, 18, 19]. Temporal artery biopsy is still 
the gold standard for diagnosing GCA. However, it is suggested when the probability of the 
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diagnosis is at least intermediate [20]. In addition, the biopsy is positive in only 60% of GCA 
patients with the involvement of the aorta and its main branches [21]. Therefore, a delayed 
diagnosis is not uncommon in this subgroup of patients. 
Our patient presented with constitutional symptoms – FUO and a pronounced weight loss. Due to 
the patient's age, clinical presentation and a family history of cancer, an unknown primary tumor 
was initially suspected. As the patient did not present with clinical signs of temporal arteritis, 
temporal artery biopsy was not considered to be a method of choice in the clinical workup before 
performing integrated PET/CT. Surprisingly, PET/CT revealed signs of large vessel vasculitis, 
leading to a strong suspicion of GCA. Temporal artery biopsy confirmed the diagnosis.  
Even though a temporal artery biopsy per se would have been sufficient to diagnose GCA in this 
case, the likelihood of a histological pattern suggesting GCA was only 60%. PET/CT was the only 
method that could enable us to clearly assess the anatomic extent of vessel wall inflammation. 
With an important limitation: it did not reveal pathological increase of FDG uptake in the temporal 
arteries. This false negative finding is due to a low spatial resolution of PET/CT in that area [11]. 
In conclusion, PET/CT seems to be a helpful method in evaluating FUO and diagnosing large 
vessel vasculitis, including GCA, especially in cases with no specific symptoms suggesting 
vascular insufficiency. The method is also interesting because of its potential in the assessment of 
disease extent and activity. Nevertheless, further studies are needed to establish more precise 
quantitative criteria for diagnosis and patient follow-up. Furthermore, PET/CT can not completely 
replace temporal artery biopsy, due to its low spatial resolution in the temporal artery area. We 
believe that the biopsy and PET/CT are complementary methods that should be used depending on 
the clinical presentation: PET/CT as a method of choice in patients presenting with 
FUO/constitutional symptoms, and biopsy in patients with specific symptoms suggesting temporal 
arteritis. 
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Fig. 1 Whole body integrated PET/CT. Coronal views (panels a and b): increased FDG uptake in 
the walls of subclavian and proximal brachial arteries (full arrows), as well as carotid arteries 
(dotted arrows) bilaterally. Sagittal view (panel c): increased FDG uptake in the walls of the 
ascending, descending and abdominal aorta (full arrows), as well as carotid arteries (dotted arrows)  
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Fig. 2 Transverse section of the superficial temporal artery. (a) Thickening of the vascular wall 
with granulomatous inflammation (hematoxylin-eosin stain, ×100) (b) Granulomatous 
inflammation consisting of mononuclear cells and some giant multinuclear cells (hematoxylin-
eosin stain, ×400) 
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Table 1. Laboratory test results at the admission to the hospital 
 
a CBC – complete blood count  
b thrombocytes, prothrombin time and activated partial thromboplastin time   
c aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase, gamma-glutamyl 
transferase, bilirubin, urea, creatinin, creatine kinase, lactate dehydrogenase, sodium, potassium, 
calcium, phosphate, urate, glucose and lipids  
d RF – rheumatoid factor 
e AST – antistreptolysin titer  
f ANA – antinuclear antibodies, including indirect immunofluorescence, antibodies to double-
stranded DNA (dsDNA), anti-histone antibodies and ENA – antibodies to extractable nuclear 
antigens (SS-A, SS-B, Sm, U1-RNP, topoisomerase I, centromere and Jo-1);  
g ANCA – anti-neutrophil cytoplasmic antibodies  
h alpha-1 globulin 5.0 g/L (↑), alpha-2 globulin  10.6 g/L (↑), beta globulin 8.2 g/L (normal), 
gamma globulin  8.5 g/L (normal) 
i  T3, T4 and TSH  
j AFP, CEA, CA 125, CA 19-9, CA 15-3, NSE and CYFRA 21-1. 
 
 
 
 
 
 
 
 
 
 
 
Laboratory test Result 
CBCa Microcytic anemia 
ESR (mm/h) 90 
CRP (mg/L) 121.0 
Ferritin (µg/L) 534.3 
Coagulation parametersb Normal 
Biochemistryc Normal 
Urinalysis Normal 
RFd Negative 
ASTe Negative 
ANA, ENAf Negative 
ANCAg Negative 
Total proteins (g/L) 67.0 (normal) 
     - Albumin (g/L) 34.7 (↓) 
     - Globulins (g/L)h 32.3 h 
Thyroid statusi Normal 
Tumor markersj Normal 
